Learn how to oppose a trade mark application or defend your own in Australia. Download our free eBook covering the opposition process, evidence, deadlines and key steps. Trade mark disputes can arise when a new application is considered too similar to an existing brand, or raises concerns about…
A festive chocolate treat and a non-alcoholic spritz have become the centre of trade mark disputes on opposite sides of the world. These cases offer a timely reminder that even seemingly descriptive or familiar product names can carry significant legal and commercial risk.
Pearce IP provides weekly reports on global biosimilars activities in the Pearce IP BioBlast®. Significant biosimilar activities for the week ending 6 November 2026 are set out below…
Pearce IP provides weekly reports on global biosimilars activities in the Pearce IP BioBlast®. Significant biosimilar activities for the week ending 30 October 2026 are set out below…
Why New Zealand Agriculture’s Global Success Makes Intellectual Property Essential. New Zealand may be small in population, but its agricultural reach is anything but. For businesses producing, developing or commercialising the products and technologies behind global food production, getting intellectual property right is an increasingly important part of protecting commercial value.
Pearce IP New Zealand. A practice with IP in its DNA. In less than two years, Pearce IP’s New Zealand practice has gone from new arrival to recognised player across the region’s leading independent IP rankings and directories. New to New Zealand. Well Established in IP. Pearce IP’s New Zealand practice may be recent, but its expertise isn’t.
Pearce IP provides weekly reports on global biosimilars activities in the Pearce IP BioBlast®. Significant biosimilar activities for the week ending 23 October 2026 are set out below…
Naomi Pearce Named Among Australia’s Patent Elite in IAM Global Leaders 2027. Pearce IP’s Founder and CEO, Naomi Pearce has again been named as one of Australia’s patent elite in the 2027 edition of IAM Global Leaders.
Pearce IP provides weekly reports on global biosimilars activities in the Pearce IP BioBlast®. Significant biosimilar activities for the week ending 16 October 2026 are set out below…
Beyond the Name. The High Court’s Wake-Up Call for Brand Owners. Can a different brand name still mislead customers? The High Court’s Bed Bath ’N’ Table decision provides key lessons for trade mark clearance & brand protection.
Pearce IP provides weekly reports on global biosimilars activities in the Pearce IP BioBlast®. Significant biosimilar activities for the week ending 9 October 2026 are set out below…
Who Owns the Future of Agriculture? IP Questions Businesses Can’t Afford to Ignore. Your next breakthrough could be worth millions. But who owns it? Who can commercialise it? And could a competitor gain access to the data, technology or know-how that gives your business its competitive edge? As agriculture, crop protection, food production and animal health evolve, the intellectual property…
Pearce IP is pleased to announce its inclusion in Asia IP’s 2026 Patent Rankings, with the firm ranked for Patent Prosecution in Australia. Pearce IP is one of a select list of firms recognised in the Australian Patent Prosecution category, reflecting the firm’s work advising clients on patent strategy, prosecution and portfolio management across Australia and internationally.
Pearce IP provides weekly reports on global biosimilars activities in the Pearce IP BioBlast®. Significant biosimilar activities for the week ending 2 October 2026 are set out below…
For organisations operating in pharmaceuticals, biotechnology, medical technology and agricultural sciences, intellectual property is often among their most valuable assets. Years of research. Significant investment. Regulatory hurdles. Clinical or field trials. Product development…
Pearce IP provides weekly reports on global biosimilars activities in the Pearce IP BioBlast®. Significant biosimilar activities for the week ending 25 September 2026 are set out below…
Pearce IP provides weekly reports on global biosimilars activities in the Pearce IP BioBlast®. Significant biosimilar activities for the week ending 18 September 2026 are set out below…
Recent reforms to streamline New Zealand’s medicines approval process may have inadvertently undermined its compliance with an international trade agreement, the CPTPP. From July 2026, New Zealand has implemented a new, fast-track pathway for the approval of pharmaceuticals under sections 22A to 22F of the Medicines Act 1981.
Pearce IP provides weekly reports on global biosimilars activities in the Pearce IP BioBlast®. Significant biosimilar activities for the fortnight ending 11 September 2026 are set out below…
Choosing a new brand can be an exciting part of launching a product, service or business. Once the preferred name has gained internal support, however, commercial momentum can build quickly: domains are secured, packaging is commissioned, regulatory documentation is prepared and marketing plans begin to take shape.
Justice Rofe of the Federal Court of Australia has delivered another decision in the long-running dispute between Kutti Bay Investments Pty Ltd (formerly Jusand Nominees Pty Ltd) and Rattlejack Innovations Pty Ltd. Justice Rofe held that Kutti Bay’s application to amend three standard patents constituted an abuse of process, as it sought to overcome earlier Court decisions in the dispute.
Pearce IP Founder and CEO Naomi Pearce is one of four Australian IP professionals ranked by WIPR in Influential Women in IP 2026. Influential Women in IP is a global ranking celebrating women whose expertise, leadership and achievements are shaping the future of IP.
Pearce IP has achieved five individual recommendations in the Lexology Index – Australia & New Zealand 2026, with CEO and Founder Naomi Pearce and Executive Helen Macpherson both recognised across multiple categories. CEO and Founder, Naomi Pearce, has been ranked for IP – Patents, Life Sciences, and IP – Trade Mark Agents & Attorneys.
Pearce IP provides weekly reports on global biosimilars activities in the Pearce IP BioBlast®. Significant biosimilar activities for the week ending 28 August 2026 are set out below…
Subscribe to our Pearce IP Blogs and BioBlast® to receive our updates via email.
